Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan

Hutter, 1992, The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence, J Inherit Metab Dis, 15, 565, 10.1007/BF01799615 McDonald, 1995, Profiles of neuromuscular diseases. Duchenne muscular dystrophy, Am J Phys Med Rehabil, 74, S70, 10.1097/00002060-199509001-00003 Drachman, 1974, Prednisone in Duchenne muscular dystrophy, Lancet, 2, 1409, 10.1016/S0140-6736(74)90071-3 Manzur, 2008, Glucocorticoid corticosteroids for Duchenne muscular dystrophy, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD003725.pub3 Rahman, 2001, Prednisolone in Duchenne muscular dystrophy, Bangladesh Med Res Counc Bull, 27, 38 Mendell, 1989, Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy, N Engl J Med, 320, 1592, 10.1056/NEJM198906153202405 Fenichel, 1991, A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy, Arch Neurol, 48, 575, 10.1001/archneur.1991.00530180027012 Pradhan, 2006, Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation, J Neurol, 253, 1309, 10.1007/s00415-006-0212-1 Connolly, 2002, High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy, Neuromuscul Disord, 12, 917, 10.1016/S0960-8966(02)00180-3 Escolar, 2011, Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy, Neurology, 77, 444, 10.1212/WNL.0b013e318227b164 Biggar, 2006, Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade, Neuromuscul Disord, 16, 249, 10.1016/j.nmd.2006.01.010 King, 2007, Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy, Neurology, 68, 1607, 10.1212/01.wnl.0000260974.41514.83 Ricotti, 2013, Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy, J Neurol Neurosurg Psychiatry, 84, 698, 10.1136/jnnp-2012-303902 Moxley, 2005, Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Neurology, 11, 13, 10.1212/01.WNL.0000148485.00049.B7 Gloss, 2016, Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology, Neurology, 86, 465, 10.1212/WNL.0000000000002337 Nishima, 1977, Flow-volume curve in healthy and asthmatic children in the non-attack stage (in Japanese), Rinsho to Kenkyu, 54, 525 Miller, 2005, Standardisation of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 Cnaan, 1997, Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data, Stat Med, 16, 2349, 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E Griggs, 2013, Corticosteroids in Duchenne muscular dystrophy: major variations in practice, Muscle Nerve, 48, 27, 10.1002/mus.23831 Hoffman, 2012, Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy, Phys Med Rehabil Clin N Am, 23, 821, 10.1016/j.pmr.2012.08.003 Moxley, 2010, Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management, J Child Neurol, 25, 1116, 10.1177/0883073810371004 Henricson, 2013, Muscle Nerve, 48, 55, 10.1002/mus.23808 Mayer, 2015, Characterization of pulmonary function in Duchenne Muscular Dystrophy, Pediatr Pulmonol, 50, 487, 10.1002/ppul.23172 Nève, 2013, Sniff nasal inspiratory pressure in the longitudinal assessment of young Duchenne muscular dystrophy children, Eur Respir J, 42, 671, 10.1183/09031936.00127712 Bonifati, 2000, A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy, Muscle Nerve, 23, 1344, 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F Backman, 1995, Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy, Neuromuscul Disord, 5, 233, 10.1016/0960-8966(94)00048-E 2014 Nakamura, 2013, Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remedy), Orphanet J Rare Dis, 8, 60, 10.1186/1750-1172-8-60 Takeuchi, 2013, Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients, J Neurol, 260, 3023, 10.1007/s00415-013-7104-y